GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Net Change in Cash

ZYUS Life Sciences (TSXV:ZYUS) Net Change in Cash : C$0.04 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

ZYUS Life Sciences's Net Change in Cash for the three months ended in Mar. 2024 was C$-3.01 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.04 Mil.

ZYUS Life Sciences Net Change in Cash Historical Data

The historical data trend for ZYUS Life Sciences's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Net Change in Cash Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
Net Change in Cash
-7.24 -0.54 3.77

ZYUS Life Sciences Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.71 15.59 -9.19 -3.34 -3.01

ZYUS Life Sciences Net Change in Cash Calculation

ZYUS Life Sciences's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-18.012+4.64+17.138+0
=3.77

ZYUS Life Sciences's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-2.638+-0.034+-0.341+0
=-3.01

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ZYUS Life Sciences Net Change in Cash Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

ZYUS Life Sciences (TSXV:ZYUS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Net Change in Cash
Comparable Companies
TSXV:DB XCNQ:HUGE TSX:CWEB XCNQ:GRIN TSX:MDP TSX:CRDL XCNQ:CXXI XCNQ:MMEN TSX:AVNT XCNQ:ACRG.A.U ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ZLSCF:USA
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
Website
https://www.zyus.com
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Executives
John Michael Hyshka Senior Officer

ZYUS Life Sciences (TSXV:ZYUS) Headlines

No Headlines